Back

Obesity paradox, weight-free anthropometric measures, and major adverse cardiovascular events in the elderly: Insight from the Northern Shanghai Study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Obesity, weight loss, and cardiovascular disease Obesity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Yi Zhang

Shanghai Tenth People's Hospital, Shanghai (China)

8 More presentations in this session

Presentation thumbnail
Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis.
Doctor L. Lobo (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Effects of SGLT-2i and GLP-1RA in vascular function parameters: the impact of the weight loss
Doctor E. Bletsa (Zurich, CH) Doctor P. Stampouloglou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of obesity and metabolic health status with cerebral small vessel disease in stroke-free individuals
Associate Professor A. ishida (Okinawa, JP)
Abstract Slides Video
Presentation thumbnail
Parallel improvement of arterial stiffness with weight loss following intensification of antidiabetic treatment
Doctor E. Bletsa (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Obesity, weight loss, and cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Is the obesity paradox leading to a less stringent secondary prevention strategy in post-acute coronary syndrome patients?
thumbnail
Congress Presentation
Clinical profile and outcomes of patients hospitalized with heart failure
thumbnail
Congress Presentation
Anthropometric measures and long-term mortality in heart failure with reduced ejection: debunking the obesity paradox

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources